Treatment of cancer-associated thrombosis: Perspectives on the use of novel oral anticoagulants

Thrombosis Research

Volumn 133, Issue SUPPL. 2, 2014, Pages

  Lee, Agnes Y Y ^a   Carrier, Marc ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Anticoagulants; Cancer; Low molecular weight heparin; Oral anticoagulant; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; DABIGATRAN; EDOXABAN; ENOXAPARIN; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CARDIOVASCULAR RISK; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; KIDNEY FAILURE; LIVER METASTASIS; LONG TERM CARE; LUNG EMBOLISM; METASTASIS; MULTICENTER STUDY (TOPIC); NEOPLASM; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VENOUS THROMBOEMBOLISM; BLOOD; COMPLICATION; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; THROMBOSIS;

ADMINISTRATION, ORAL; ANTICOAGULANTS; HUMANS; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; THROMBOSIS;

EID: 84901474535     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(14)50027-8     Document Type: Article

References (27)

1. A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 Suppl 1 2003 I17 I21
2. A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients Cancer 110 2007 2339 2346 (Pubitemid 350100757)
3. L.S. Elting, C.P. Escalante, C. Cooksley, E.B. Avritscher, D. Kurtin, and L. Hamblin et al. Outcomes and cost of deep venous thrombosis among patients with cancer Arch Intern Med 164 2004 1653 1661 (Pubitemid 39037944)
4. H.T. Sorensen, L. Mellemkjaer, J.H. Olsen, and J.A. Baron Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 2000 1846 1850 (Pubitemid 32104130)
5. M. Mandala, A. Falanga, and F. Roila Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines Ann Oncol 22 Suppl 6 2011 vi85 vi92
6. G.H. Lyman, A.A. Khorana, N.M. Kuderer, A.Y. Lee, J.I. Arcelus, and E.P. Balaban et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update J Clin Oncol 31 2013 2189 2204
7. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology Venous Thromboembolic Disease Version 2.2011. Accessed November 26, 2013. National Comprehensive Cancer Network, http://www.nccn.org/professionals/ physician-gls/f-guidelines.asp#supportive.
8. S.R. Kahn, W. Lim, A.S. Dunn, M. Cushman, F. Dentali, and E.A. Akl et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl 2012 e195S e226S
9. C.W. Francis Prevention of venous thromboembolism in hospitalized patients with cancer J Clin Oncol 27 2009 4874 4880
10. R. Alikhan, A.T. Cohen, S. Combe, M.M. Samama, L. Desjardins, and A. Eldor et al. Prevention of venous thromboembolism in medical patients with enoxaparin: A subgroup analysis of the MEDENOX study Blood Coagul Fibrinolysis 14 2003 341 346 (Pubitemid 36688187)
11. M. Carrier, P. Moretto, G. Le Gal, R. Karp, and J.I. Zwicker Lack of data to support thromboprophylaxis in hospitalized cancer patients Am J Med 127 2014 82 86
12. R. Alikhan, and A.T. Cohen Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction) Cochrane Database Syst Rev 2009 CD003747
13. F. Dentali, J.D. Douketis, M. Gianni, W. Lim, and M.A. Crowther Meta-analysis: Anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients Ann Intern Med 146 2007 278 288 (Pubitemid 351650614)
14. S.Z. Goldhaber, A. Leizorovicz, A.K. Kakkar, S.K. Haas, G. Merli, and R.M. Knabb et al. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients N Engl J Med 365 2011 2167 2177
15. A.T. Cohen, T.E. Spiro, and A.C. Spyropoulos Rivaroxaban for thromboprophylaxis in acutely ill medical patients N Engl J Med 368 2013 1945 1946
16. M.N. Levine, C. Gu, H.A. Liebman, C.P. Escalante, S. Solymoss, and D. Deitchman et al. A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer J Thromb Haemost 10 2012 807 814
17. M. Carrier, G. Le Gal, R. Cho, S. Tierney, M. Rodger, and A.Y. Lee Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients J Thromb Haemost 7 2009 760 765
18. A.Y. Lee, and E.A. Peterson Treatment of cancer-associated thrombosis Blood 122 2013 2310 2317
19. M.F. Barginear, R.J. Gralla, T.P. Bradley, S.S. Ali, I. Shapira, and C. Greben et al. Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial Support Care Cancer 20 2012 2865 2872
20. S. Schulman, C. Kearon, A.K. Kakkar, P. Mismetti, S. Schellong, and H. Eriksson et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med 361 2009 2342 2352
21. R. Bauersachs, S.D. Berkowitz, B. Brenner, H.R. Buller, H. Decousus, and A.S. Gallus et al. Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
22. H.R. Buller, M.H. Prins, A.W. Lensin, H. Decousus, B.F. Jacobson, and E. Minar et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N Engl J Med 366 2012 1287 1297
23. G. Agnelli, H.R. Buller, A. Cohen, M. Curto, A.S. Gallus, and M. Johnson et al. Oral apixaban for the treatment of acute venous thromboembolism N Engl J Med 369 2013 799 808
24. H.R. Buller, H. Decousus, M.A. Grosso, M. Mercuri, S. Middeldorp, and M.H. Prins et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism N Engl J Med 369 2013 1406 1415
25. G.E. Raskob, H. Buller, P. Angchaisuksiri, D. Oh, Z. Boda, and R.M. Lyons et al. Edoxaban for long-term treatment of venous thromboembolism in cancer patients Blood 122 2013 211 (abstract)
26. F.F. Van Doormaal, G.E. Raskob, B.L. Davidson, H. Decousus, A. Gallus, and A.W. Lensing et al. Treatment of venous thromboembolism in patients with cancer: Subgroup analysis of the Matisse clinical trials Thromb Haemost 101 2009 762 769
27. E.A. Nutescu, S.A. Spinler, A. Wittkowsky, and W.E. Dager Low-molecular-weight heparins in renal impairment and obesity: Available evidence and clinical practice recommendations across medical and surgical settings Ann Pharmacother 43 2009 1064 1083